Jubilant Ingrevia commissions facility for diketenes and derivativesIllustrative image – not actual.
Jubilant Ingrevia, a global integrated life science products and innovative solutions provider, has announced the commissioning of its new diketene derivatives facility at its manufacturing site at Gajraula, Uttar Pradesh. 
 
The newly commissioned facility marks the entry of Jubilant Ingrevia into the fast growing diketene business portfolio.  In the recent years the company has developed a range of diketene derivatives.
 
The commissioned facility has about 7,000 tpa capacity to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate).  
 
The company’s association with customers in Pharmaceuticals, Agrochemicals and other industries and its efforts to get product approval from customers, will help in utilising a major portion of the capacity of this new facility in the coming months. 
 
Jubilant Ingrevia undertakes to commission future phases of Diketene Derivatives as per plan.
← All latest storiesBack to top →